Form 8-K - Current report:
SEC Accession No. 0001493152-22-006514
Filing Date
2022-03-10
Accepted
2022-03-10 16:30:23
Documents
16
Period of Report
2022-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44159
2 ex99-1.htm EX-99.1 56405
3 ex99-2.htm EX-99.2 95522
4 ex99-1_001.jpg GRAPHIC 8132
  Complete submission text file 0001493152-22-006514.txt   453970

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hrow-20220310.xsd EX-101.SCH 3756
6 XBRL DEFINITION FILE hrow-20220310_def.xml EX-101.DEF 27289
7 XBRL LABEL FILE hrow-20220310_lab.xml EX-101.LAB 37534
8 XBRL PRESENTATION FILE hrow-20220310_pre.xml EX-101.PRE 25908
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5550
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 22729460
SIC: 2834 Pharmaceutical Preparations